Finding 1236136 (2024-001)

Material Weakness Repeat Finding
Requirement
A
Questioned Costs
-
Year
2024
Accepted
2026-09-23
Audit: 411767
Organization: Pop Biotechnologies Inc. (NY)

AI Summary

  • Core Issue: POP Biotechnologies Inc. lacks a formal process for maintaining and storing bank reconciliations.
  • Impacted Requirements: This violates 2 CFR § 200.303(a) regarding effective internal controls over federal awards.
  • Recommended Follow-Up: Implement monthly bank reconciliation procedures and ensure documentation is retained for audits and management review.

Finding Text

Criteria: 2 CFR § 200.303(a) requires the establishment and maintenance of effective internal control over federal awards to provide reasonable assurance of compliance with federal statutes, regulations, and the terms and conditions of the federal award Condition: During our audit, we noted that POP Biotechnologies Inc. does not maintain or store bank reconciliations on file. There is no evidence of a formal process for reconciling cash balances on a regular basis. Cause: The organization has not established or implemented procedures requiring the preparation and retention of bank reconciliations. Effect or Potential Effect: Failure to perform and retain bank reconciliations increases the risk of errors or irregularities in cash balances going undetected, which could result in misstatements in the financial statements and noncompliance with federal requirements. Known Questioned Costs: None identified. Perspective Information: This issue was identified for all bank accounts reviewed during the audit period, indicating a systemic deficiency. Identification of Repeat Findings: This is a new finding for the current year. Recommendation: We recommend that POP Biotechnologies Inc. implement procedures to ensure that bank reconciliations are prepared and reviewed monthly, and that documentation is retained for audit and management review.

Corrective Action Plan

In 2025, POP Biotechnologies, Inc is implementing new bank reconciliation process. It will use the QuickBooks Bank reconciliation feature to perform reconciliations of cash balances in bank accounts.

Categories

Internal Control / Segregation of Duties

Other Findings in this Audit

  • 1236137 2024-002
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.395 CANCER TREATMENT RESEARCH $320,941
93.866 AGING RESEARCH $233,258
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $94,274
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $35,210